<DOC>
	<DOCNO>NCT01199757</DOCNO>
	<brief_summary>Previous publication indicate Allergic Rhinitis ( AR ) patient suffer ocular nasal symptom great burden illness low quality life patient suffer nasal symptom alone . Fluticasone furoate ( FF ) act nasal ocular symptom . The purpose study evaluate difference symptom control ( perceptually objectively ) resource use patient current seasonal AR .</brief_summary>
	<brief_title>A Comparison Patients AVAMYS ® Versus NASONEX ( A Trade Mark Schering Corporation ) FLIXONASE ® Key Health Outcome Measures</brief_title>
	<detailed_description>- Allergic rhinitis ( AR ) common inflammatory condition upper respiratory tract , nasal cavity eye affect 20 % population United States Europe . The bothersome nature AR symptom severely affect daily activity include ability work examination performance impact quality life ( QoL ) psychosocial well . - This study assess impact Fluticasone furoate ( FF ) QoL seasonal allergic rhinitis ( SAR ) patient , include number symptom-free day ( SFD ) quality life last 4 week , compare inhale nasal steroid ( INS ) : mometasone furate ( MF ) fluticasone proprionate ( FP ) . - Selected physician provide information include range demographic , symptom treatment detail number SAR patient . The patient invite provide detail SAR include symptom , impact AR upon lifestyle , attitude treatment completion Health Related Quality Life ( HRQoL ) instrument .</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Patient Current Seasonal Allergic Rhinitis sufferer ( base physician judgement ) Currently receive prescribe INS treatment ( treatment restriction apply ) Have consume least one full prescription specify INS treatment No comorbid Asthma COPD diagnosis Informed Consent None specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>ocular symptom</keyword>
	<keyword>nasal symptom</keyword>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Symptom Free Days</keyword>
	<keyword>Quality Life</keyword>
</DOC>